Search results
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters via AOL· 6 days agoEvidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart...
10 Reasons to Buy Eli Lilly Stock Now
247wallst.com· 2 days agoOne such company that’s now increasingly viewed as a growth play is Eli Lilly (NYSE: LLY). With this in mind, let’s dive into the top 10 reasons...
Top Stock Reports for Berkshire Hathaway, Eli Lilly & PepsiCo
Zacks via Yahoo Finance· 1 day agoToday's Research Daily features new research reports on 16 major stocks, including Berkshire...
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
Motley Fool via Yahoo Finance· 20 hours agoAnd the pill version has also been achieving promising results in early trials. But even if the drug...
Employer coverage for weight-loss drugs rises sharply, survey finds By Reuters
Investing.com· 3 days agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
Los Angeles Times· 4 days agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 5 days agoHowever, the title now belongs to Eli Lilly (NYSE: LLY) -- and it isn't even close. Lilly...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 5 days agoWith its stock price fast approaching $1000 per share, drugmakerEli lilly is poised for a forward...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
LA Times via Yahoo News· 4 days agoResearchers at McAfee have found a near tripling in the number of phishing attempts and malicious...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity ...
The Motley Fool· 2 days agoWegovy's market-topping position is precarious. Here are three drugs most likely to dethrone Novo...